期刊文献+

白细胞介素-1α基因启动子区域C-889T多态与冠心病的相关性

Correlation between the polymorphism in the promoter region of interleukin-1α gene with the coronary heart disease
下载PDF
导出
摘要 目的:研究白细胞介素-1α(interleukin-1α,IL-1α)基因启动子区域-889位C→T多态与冠心病(CH D)的相关性。方法:运用M ALDI-TOF质谱检测技术,对上海地区94例血压正常的CH D患者和100名健康对照者进行C-889T多态基因分型。结果:C-889T多态的基因型分布在CH D组(CC=83、CT=11)和对照组(76、24)间差异有显著性(P=0.026)。C、T等位基因频率与对照组相比差异亦有显著性(94.15%、5.85%/88.00%、22.00%,P=0.035)。在多支病变组中,C-889T多态的基因型分布及其等位基因频率与对照组相比差异均有显著性(46、5/76、24,P=0.036;95.10%、4.90%/88.00%、22.00%,P=0.048)。结论:IL-1α基因启动子区域的C-889T多态可能是血压正常人群CH D发病的一个遗传性危险因素,并且还可能与冠状动脉粥样硬化的病变程度相关。 Objective To analyze the correlation between the C/T polymorphism at position -889 in the promoter region of interleukin-1α (IL-1α) gene and the coronary heart disease (CHD) in Shanghai. Methods MALDI-TOF MassARRAY system was used to genotyping the C-889T polymorphism in 94 normotensive patients with CHD and 100 healthy controls. Results The genotype distribution of the C-889T polymorphism was significantly different between the CHD group (CC=83, CT=11) and the controls (CC=76, CT=24; P=0.026). The frequencies of C and T alleles were also obviously different between the two groups(94.15% and 5.85% vs 88.00% and 22.00%;P=0.035). The genotype distribution and alleles frequencies of the C-889T polymorphism were obviously different between the patients with double-vessel disease (DVD) and triple-vessel disease (TVD) and controls (46 and 5 vs 76 and 24, P=0.036; 95.10% and 4.90% vs 88.00% and 22.00%, P=0.048). Conclusions The C-889T polymorphism in the promoter region of IL-1α gene might be a genetic risk factor for CHD in normotensive patients, which might be also associated with the extent of coronary atherosclerosis.
出处 《诊断学理论与实践》 2005年第2期130-132,共3页 Journal of Diagnostics Concepts & Practice
  • 相关文献

参考文献13

  • 1[1]Ross R. Atherosclerosis--an inflammatory disease [J].N Engl J Med, 1999,340(2):115-126.
  • 2[2]Keller TT, Mairuhu AT, de Kruif MD,et al. Infections and endothelial cells[J]. Cardiovasc Res, 2003,60(1):40-48.
  • 3[3]Calabrese F, van der Wal, Levi M. Infection and inflammation in the cardiovascular system[J]. Cardiovasc Res,2003,60(1):1-4.
  • 4[4]Saadeddin SM,Habbab MA,Ferns GA. Markers of inflammation and coronary artery disease [J]. Med Sci Monit,2002,8(1):RA5-12.
  • 5[5]Vorchheimer DA,Fuster V.Inflammatory markers in coronary artery disease[J]. JAMA, 2001,286(17):2154-2156.
  • 6[6]Dinarello CA,Wolff SM. The role of interleukin-1 in disease[J]. N Engl J Med, 1993,328(2):106- 113.
  • 7[7]Dinarello CA. Biological basis for interleukin-1 in disease[J].Blood, 1996,87(6):2095-2147.
  • 8[8]Feingold KR, Memon RA, Moser AH,et al. Endotoxin and interleukin-1 decrease hepatic lipase mRNA levels[J]. Atherosclerosis, 1999,142(2): 379-387.
  • 9[9]Waehre T, Yndestad A, Smith C,et al. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors[J].Circulation,2004,109(16): 1966-1972.
  • 10[10]Tipping PG, Hancock WW. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques[J]. Am J Pathol, 1993,142(6):1721-1728.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部